12:00 AM
Jun 24, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

bluebird bio completes IPO

bluebird bio Inc. (NASDAQ:BLUE), Cambridge, Mass.
Business: Gene/Cell therapy, Hematology, Neurology

Read the full 40 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >